| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1459768A2 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 09/22/2004 | EP1459766A1 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/22/2004 | EP1459762A1 Preventives remedies for proliferative organ diseases chronic arthritic diseases hypertrophic scar or keloid |
| 09/22/2004 | EP1459761A1 A pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459754A1 Preventives/remedies for cancer |
| 09/22/2004 | EP1459752A2 Bisdioxopiperazine for the treatment of accidental extravasation of anthracyclines |
| 09/22/2004 | EP1459070A2 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers |
| 09/22/2004 | EP1458870A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458858A2 Histone h3 methyltransferase polypeptide |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458742A2 Solvates of 3.beta.,28-diacetoxy-18-oxo-19,20,21,29,30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458737A2 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 09/22/2004 | EP1458734A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
| 09/22/2004 | EP1458726A2 Mitotic kinesin inhibitors |
| 09/22/2004 | EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/22/2004 | EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 09/22/2004 | EP1458720A1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 09/22/2004 | EP1458718A1 Quinolinones as prostaglandin receptor ligands |
| 09/22/2004 | EP1458717A1 Aroyl pyridinones |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458713A1 Indolinone derivatives useful as protein kinase inhibitors |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458706A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 09/22/2004 | EP1458702A1 Luminacin analogs and uses thereof |
| 09/22/2004 | EP1458697A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458688A1 Quinazolinone derivative |
| 09/22/2004 | EP1458686A1 Benzocyclodecane derivatives with antitumor activity |
| 09/22/2004 | EP1458683A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 09/22/2004 | EP1458676A2 Compounds for the treatment of inflammatory disorders |
| 09/22/2004 | EP1458410A2 Stabilised mrna tumour vaccine |
| 09/22/2004 | EP1458404A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 09/22/2004 | EP1458392A2 Acridone inhibitors of impdh enzyme |
| 09/22/2004 | EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 09/22/2004 | EP1458380A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 09/22/2004 | EP1458379A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458365A1 Improved polymer-lipid delivery vehicles |
| 09/22/2004 | EP1458242A2 Polyvalent conjugate vaccine for cancer |
| 09/22/2004 | EP1268389B1 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1196428B1 11-beta-aryl-17,17-spirothiolane-substituted steroids |
| 09/22/2004 | EP1196144B1 A liposome composition having resistance to freeze/thaw damage |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1163264B1 Novel lhrh antagonists with improved solubility characteristics |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1140860B1 Pyrimidine compounds |
| 09/22/2004 | EP1135161B1 Chemotherapeutic composition and method |
| 09/22/2004 | EP1124820B1 Lipoic acid derivatives and their use in treatment of disease |
| 09/22/2004 | EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP1005539B1 Ikk-alpha proteins, nucleic acids and methods |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0866800B1 Antineoplastic peptides |
| 09/22/2004 | EP0768885B1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531553A WT1 modified peptide |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531538A 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531526A Diaminedithiol derivatives and radiorhenium or radoitechnetium complex thereof; liver cancer-treating composition comprising radiorhenium complex and lipiodol; and kit for preparation of liver cancer |
| 09/22/2004 | CN1531445A Biotin-derivatives and their conjugates with chelating agents |
| 09/22/2004 | CN1531442A Perylenequinones for use as photosensitizers and sonosensitizers |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531439A Liposome targeting of matrix metalloproteinase inhibitors |
| 09/22/2004 | CN1531435A Methods for inhibiting angiogenesis |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1531424A SN-38 lipid complexes and methods of use |
| 09/22/2004 | CN1530371A Fructose spiro-compound with anti-cancer activity |
| 09/22/2004 | CN1530133A Medicine for treating lung cancer |
| 09/22/2004 | CN1530116A Chinese medicine for treating tumour and preparing method thereof |
| 09/22/2004 | CN1530099A Fumagucin injection against cancers and its preparing method |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167678C 新颖的维生素d类似物 Novel analogues of vitamin d |
| 09/22/2004 | CN1167469C Preparation of nano particles of hydroxycamptothecine polylactate |
| 09/22/2004 | CN1167441C Xiangshen capsule and preparation and use thereof |
| 09/22/2004 | CN1167439C Anticancer Chinese herbal emdicine and its preparation |
| 09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |